EUVIMEDEUVIMED entdecken
Crossref

Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk?

Yannic Volz, Rabea Trappmann, Benedikt Ebner, Lennert Eismann, Benazir Enzinger, Julian Hermans, Nikolaos Pyrgidis, Christian Stief, Gerald B Schulz

Urologia Internationalis · 2024

DOI: 10.1159/000535024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Urologia Internationalis, 2024. Verfasst von Yannic Volz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Transurethral Resection of Bladder. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Transurethral resection of the bladder (TUR-BT) is the standard initial treatment and diagnosis of bladder cancer (BC). Of note, upstaging into muscle-invasive disease (MIBC) during re-resection occurs in a significant proportion of patients. This study aimed to define risk factors at initial TUR-BT for upstaging.

Methods

TUR-BT between 2009 and 2021 were retrospectively screened (n = 3,237). We included patients with visible tumors that received their primary and re-TUR-BT at our institution. Upstaging was defined as pathological tumor stage progression into MIBC at re-TUR-BT. Clinicopathological variables were analyzed for the impact on upstaging.

Results

Two hundred and sixty-six patients/532 TUR-BTs were included in the final analysis. Upstaging occurred in 7.9% (21/266) patients. Patients with upstaging presented with stroma-invasive and papillary non-muscle-invasive BC at primary resection in 85.7% (18/21) and 14.3% (3/21), respectively. Detrusor muscle at primary TUR-BT was significantly less present in patients with upstaging (4.1 vs. 95.9%; p < 0.001). After multivariate analysis, solid tumor configuration (HR: 4.17; 95% CI: 1.23–14.15; p = 0.022) and missing detrusor muscle at initial TUR-BT (HR: 3.58; 95% CI: 1.05–12.24; p = 0.043) were significant risk factors for upstaging into MIBC.

Conclusions

The current study defined two major risk factors for upstaging: missing detrusor muscle and solid tumor configuration. We propose that a second resection should be performed earlier if these risk factors apply.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsNon-Muscle Invasive Bladder NeoplasmsTransurethral Resection of BladderHumansNeoplasm Recurrence, LocalRetrospective StudiesUrinary BladderUrologic Surgical Procedures

Stichwörter der Autor:innen

CarcinomaMuscle-invasive diseasePathologyQuality controlSurgical procedureTransitional cellUpstagingUrinary bladder neoplasms

Autor:innen und Institutionen

  • Department of Urology, University Hospital, LMU Munich, Munich, Germany.

Zitieren

APA

Volz, Y., Trappmann, R., Ebner, B., Eismann, L., Enzinger, B., Hermans, J., Pyrgidis, N., Stief, C., & Schulz, G. B. (2024). Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk?. Urologia Internationalis. https://doi.org/10.1159/000535024

Vancouver

Volz Y, Trappmann R, Ebner B, Eismann L, Enzinger B, Hermans J, et al. Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk?. Urologia Internationalis. 2024. doi:10.1159/000535024

BibTeX
@article{Volz2024,
  author = {Volz, Yannic and Trappmann, Rabea and Ebner, Benedikt and Eismann, Lennert and Enzinger, Benazir and Hermans, Julian and Pyrgidis, Nikolaos and Stief, Christian and Schulz, Gerald B},
  title = {Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk?},
  journal = {Urologia Internationalis},
  year = {2024},
  doi = {10.1159/000535024}
}
Kostenlos starten →